Albireo Pharma inc (ALBO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ALBO Annual Balance Sheets →
Tracking balance sheet results across Albireo Pharma inc to Sep 30 2021 helps illustrate how Sep 30 2022's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent222.48
Cash & Short-term Investments222.00
Accounts receivable2.03
Inventories3.15
Other Current Assets2.67
Prepaid Expense, Current AS8.52
Total Current Assets238.84
Equipment/Property/Plant Net1.30
Goodwill net17.26
Other Assets, Noncurrent63.82
Total Assets321.22
Liabilities
Accounts Payable, Trade, Current6.95
Accrued Liabilities, Current AC25.37
Notes Payable, Current NO0.00
Other Liabilities, Current5.50
Total Current Liabilities37.82
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent183.33
Total Liabilities221.15
Stockholders' Equity
Common Stock Value0.21
Treasury Stock Value0.00
Additional Paid In Capital Common Stock512.92
Retained Earnings / Accumulated Deficit-421.03
Other Equity7.98
Common Stockholder's Equity100.07
Total Stockholder's Equity100.07
Liabilities & Stockholder's Equity321.22
4 historic quarters locked

Sign in to unlock the full Albireo Pharma inc balance sheet history.

About Albireo Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-22-016893

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.